Judith Anderton - Concepedia

Author

Judith Anderton

Also Known As

J. Anderton, Judith Anderton

100

Publications

720

Citations

H-Index

Concepts

All Affiliations

Judith Anderton is an author at AstraZeneca (United Kingdom) specializing in tumor biology, cancer research, and cell biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	443
2	Cell Biology	2	2	443
3	Health Sciences	1	1	407
4	Immunology	1	1	407
5	Molecular Biology	1	1	36

Judith Anderton

Publications

589

Citations

H-Index

Page 1

	Year	Citations
Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson, Cancer Immunology Research ImmunologyImmunoeditingImmunotherapeutic Drug DiscoveryImmunotherapeuticsImmunotherapy	2016	407
AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer D. Mark Hickinson, Teresa Klinowska, Georgina Speake, Clinical Cancer Research	2010	118
Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors Bernard Barlaam, Judith Anderton, Peter Ballard, ACS Medicinal Chemistry Letters Her3 ReceptorsMolecular BiologyTumor BiologyHer2 Kinase DomainSignaling Pathway	2013	36
A B7-H4–Targeting Antibody–Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant Cancers with B7-H4 Expression Sarah B. Gitto, Margaret Whicker, Gareth Davies, Clinical Cancer Research	2023	28

Page 1